Entera Bio (ENTX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Entera Bio (ENTX) is Neutral.

The composite score behind that read is +0.08, weighing +0.19 of bullish evidence against -0.23 bearish.

Entera Bio last closed at $2.65, -0.38% on the session.

Against the IVW growth benchmark the position is +0.05% over the forecast window.

The read is built from 14 underlying insights — 4 bullish and 10 bearish.

Agreement across those insights is 71%.

Entera Bio has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Entera Bio in the 7th percentile on return on equity, where 100 is best.

Entera Bio is classified under Health Care / Biotechnology, with a market capitalisation of $462.40M.

StockMap tracks Entera Bio as the 188th largest of the 386 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 307 Neutral, 66 Moderate Underperform and 13 Moderate Outperform.

On that composite Entera Bio ranks 49th of 386 in the group, against a group median of -0.08.